Developer docs
API playgroundTry for free, no card

Search company profiles

Cowen Healthcare Investments

Full company profile

uuid0000kp1

Namestring
Cowen Healthcare Investments
Legal namestring
TD Securities Inc.
Websiteurl
cowen.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Cowen Healthcare Investments is a financial services franchise focused on healthcare and life sciences investment banking and asset management, originally founded in 2016 and headquartered in New York. The firm provides capital markets solutions, M&A advisory, equity research, and strategic advisory services to healthcare companies, operating today as TD Cowen — the healthcare and life sciences division of TD Securities Inc., which is itself a subsidiary of The Toronto-Dominion Bank (TD Bank Group), one of Canada's largest banks listed on the Toronto Stock Exchange (TSX: TD). Kevin Raidy serves as Managing Partner of the franchise.

The company's core offering centers on professional services revenue generated through investment banking engagements, including capital raising, M&A advisory, and equity research distribution. It does not maintain a proprietary technology platform; rather, its value is delivered through senior banker expertise, institutional relationships, and the distribution infrastructure of TD Securities. The firm reaches clients via direct enterprise field sales, supplemented by thought-leadership channels such as the TD Cowen Insights Podcast, annual Research Themes Reports, dedicated Health Care Industry Coverage, and media engagement.

The franchise is vertically specialized in the healthcare and life sciences sector, serving enterprise clients including corporations, financial sponsors, and institutional investors across North America (Canada, United States) and Asia Pacific (Japan). Operating as a division of a major Canadian bank provides access to global institutional distribution, regulated capital markets infrastructure, and cross-border deal capabilities, but also means Cowen Healthcare Investments does not operate as an independent standalone entity with separately disclosed financials.

Short descriptiontext

Cowen Healthcare Investments is the healthcare and life sciences investment banking division of TD Securities (operating as TD Cowen), providing M&A advisory, capital markets, and equity research services to healthcare companies across North America and Asia Pacific.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare investment banking, M&A advisory, capital markets services, equity research, healthcare advisory
Industry1 code
PRIMARYFSAHAAAK
Equity Long/Short — Healthcare Focus
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code2 codes
  • Investment Advice6282
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Healthcare Investment Banking
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Banking Services
TypeProfessional Services
Description

TD Cowen generates revenue through investment banking services including M&A advisory, capital markets transactions, and strategic advisory for healthcare and life sciences companies.

tdsecurities.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cowen Healthcare Investments, operating as TD Cowen, provides investment banking services to healthcare and life sciences companies. Its core offerings include M&A advisory, capital markets transactions (equity and debt financing), equity research coverage, and strategic advisory tailored to the healthcare sector. The practice leverages TD Securities' institutional platform to deliver full-service investment banking to corporate healthcare clients.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1M&A Advisory
CategoryInvestment Banking
Description

Buy-side and sell-side M&A advisory services for healthcare and life sciences companies, provided as part of TD Cowen / TD Securities' corporate and investment banking offering.

2Capital Markets Services
CategoryInvestment Banking
Description

Equity and debt capital markets execution and underwriting for healthcare issuers, leveraging TD Securities' institutional platform.

3Equity Research
CategoryInvestment Banking
Description

Healthcare and life sciences equity research coverage distributed to institutional clients and investors through TD Securities' research platform.

4Strategic Advisory
CategoryInvestment Banking
Description

Strategic consulting and advisory services for healthcare companies seeking transaction and corporate finance guidance.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Jefferies runs a dedicated healthcare investment banking and equity research franchise with deep vertical specialization across biotech, medtech, and healthcare services. It competes head-to-head with TD Cowen for mid-market healthcare M&A, IPOs, and follow-on mandates from the same client base.

TypeDirect peer
Description

Guggenheim Securities operates a focused healthcare investment banking practice serving biotech, pharma, and medical device clients with M&A advisory and capital markets services. Like TD Cowen, it is a mid-market-focused healthcare specialist rather than a bulge-bracket full-service bank.

TypeDirect peer
Description

Piper Sandler has a long-standing healthcare investment banking franchise covering medical devices, diagnostics, and healthcare services. It is directly comparable to TD Cowen in target client (growth-stage healthcare companies), deal size focus, and service mix.

TypeDirect peer
Description

Cantor Fitzgerald operates a healthcare investment banking practice with strong biotech and specialty pharma coverage. It competes directly with TD Cowen for healthcare M&A advisory and capital markets mandates, with comparable mid-market positioning.

TypeDirect peer
Description

SVB Securities — now part of First Citizens following the Silicon Valley Bank acquisition — has a leading healthcare investment banking franchise focused on life sciences tools, diagnostics, and biotech. It is directly comparable to TD Cowen's healthcare vertical in client type and service offering.

TypeDirect peer
Description

OrbiMed is a dedicated healthcare-focused investment firm managing public and private healthcare equity strategies. It represents the purest direct peer for the Cowen Healthcare Investments alternative investment product in terms of healthcare-only investment mandate.

TypeEmerging player
Description

Centerview Partners has built a leading healthcare M&A advisory practice alongside its broader consumer and technology coverage. It competes with TD Cowen on premium healthcare M&A mandates, though its franchise is broader than pure-play healthcare.

TypeBroad incumbent
Description

Goldman Sachs' Global Healthcare Group is the bulge-bracket leader in healthcare M&A and equity capital markets. It competes with TD Cowen on large-cap healthcare deals and sets the league-table standard the firm benchmarks against.

TypeBroad incumbent
Description

JP Morgan runs one of the largest healthcare investment banking franchises globally, covering biopharma, medical devices, and healthcare services. It competes with TD Cowen across the healthcare M&A spectrum and represents the dominant bulge-bracket alternative.

TypeBroad incumbent
Description

Lazard operates a dedicated healthcare M&A advisory practice as part of its broader financial advisory franchise. It is directly comparable to TD Cowen's healthcare advisory work but operates at a higher average deal size and broader sector scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment80 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cowen Healthcare Investments

Healthcare Investment Bankingcowen.com

Cowen Healthcare Investments is the healthcare and life sciences investment banking division of TD Securities (operating as TD Cowen), providing M&A advisory, capital markets, and equity research services to healthcare companies across North America and Asia Pacific.

What Cowen Healthcare Investments does

Cowen Healthcare Investments is a financial services franchise focused on healthcare and life sciences investment banking and asset management, originally founded in 2016 and headquartered in New York. The firm provides capital markets solutions, M&A advisory, equity research, and strategic advisory services to healthcare companies, operating today as TD Cowen — the healthcare and life sciences division of TD Securities Inc., which is itself a subsidiary of The Toronto-Dominion Bank (TD Bank Group), one of Canada's largest banks listed on the Toronto Stock Exchange (TSX: TD). Kevin Raidy serves as Managing Partner of the franchise.

The company's core offering centers on professional services revenue generated through investment banking engagements, including capital raising, M&A advisory, and equity research distribution. It does not maintain a proprietary technology platform; rather, its value is delivered through senior banker expertise, institutional relationships, and the distribution infrastructure of TD Securities. The firm reaches clients via direct enterprise field sales, supplemented by thought-leadership channels such as the TD Cowen Insights Podcast, annual Research Themes Reports, dedicated Health Care Industry Coverage, and media engagement.

The franchise is vertically specialized in the healthcare and life sciences sector, serving enterprise clients including corporations, financial sponsors, and institutional investors across North America (Canada, United States) and Asia Pacific (Japan). Operating as a division of a major Canadian bank provides access to global institutional distribution, regulated capital markets infrastructure, and cross-border deal capabilities, but also means Cowen Healthcare Investments does not operate as an independent standalone entity with separately disclosed financials.

Cowen Healthcare Investments firmographics

Firmographics
Name
Cowen Healthcare Investments
Legal name
TD Securities Inc.
Website
https://cowen.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Cowen Healthcare Investments is the healthcare and life sciences investment banking division of TD Securities (operating as TD Cowen), providing M&A advisory, capital markets, and equity research services to healthcare companies across North America and Asia Pacific.
Ownership category
akta.pro rank

Cowen Healthcare Investments industry classification

Industry
Product category
Healthcare Investment Banking
NAICS
Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSAHAAAK
Equity Long/Short — Healthcare Focus

Keywords

  • Healthcare investment banking
  • M&A advisory
  • Capital markets services
  • Equity research
  • Healthcare advisory

Where Cowen Healthcare Investments is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Cowen Healthcare Investments business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Investment Banking Services: TD Cowen generates revenue through investment banking services including M&A advisory, capital markets transactions, and strategic advisory for healthcare and life sciences companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Cowen Healthcare Investments product offering

Product offering

Core offering

Cowen Healthcare Investments, operating as TD Cowen, provides investment banking services to healthcare and life sciences companies. Its core offerings include M&A advisory, capital markets transactions (equity and debt financing), equity research coverage, and strategic advisory tailored to the healthcare sector. The practice leverages TD Securities' institutional platform to deliver full-service investment banking to corporate healthcare clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • M&A Advisory Buy-side and sell-side M&A advisory services for healthcare and life sciences companies, provided as part of TD Cowen / TD Securities' corporate and investment banking offering.
  • Capital Markets Services Equity and debt capital markets execution and underwriting for healthcare issuers, leveraging TD Securities' institutional platform.
  • Equity Research Healthcare and life sciences equity research coverage distributed to institutional clients and investors through TD Securities' research platform.
  • Strategic Advisory Strategic consulting and advisory services for healthcare companies seeking transaction and corporate finance guidance.

Companies that use Cowen Healthcare Investments

Customer profile

Segments1 record

Ideal customer profiles1 record

Cowen Healthcare Investments technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cowen Healthcare Investments partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Cowen Healthcare Investments competitors and assessment

Company assessment

Direct peers

  • Jefferies Healthcare Group: Jefferies runs a dedicated healthcare investment banking and equity research franchise with deep vertical specialization across biotech, medtech, and healthcare services. It competes head-to-head with TD Cowen for mid-market healthcare M&A, IPOs, and follow-on mandates from the same client base.
  • Guggenheim Securities Healthcare: Guggenheim Securities operates a focused healthcare investment banking practice serving biotech, pharma, and medical device clients with M&A advisory and capital markets services. Like TD Cowen, it is a mid-market-focused healthcare specialist rather than a bulge-bracket full-service bank.
  • Piper Sandler Healthcare: Piper Sandler has a long-standing healthcare investment banking franchise covering medical devices, diagnostics, and healthcare services. It is directly comparable to TD Cowen in target client (growth-stage healthcare companies), deal size focus, and service mix.
  • Cantor Fitzgerald Healthcare: Cantor Fitzgerald operates a healthcare investment banking practice with strong biotech and specialty pharma coverage. It competes directly with TD Cowen for healthcare M&A advisory and capital markets mandates, with comparable mid-market positioning.
  • SVB Securities (First Citizens): SVB Securities — now part of First Citizens following the Silicon Valley Bank acquisition — has a leading healthcare investment banking franchise focused on life sciences tools, diagnostics, and biotech. It is directly comparable to TD Cowen's healthcare vertical in client type and service offering.
  • OrbiMed Advisors: OrbiMed is a dedicated healthcare-focused investment firm managing public and private healthcare equity strategies. It represents the purest direct peer for the Cowen Healthcare Investments alternative investment product in terms of healthcare-only investment mandate.

Emerging players

  • Centerview Partners: Centerview Partners has built a leading healthcare M&A advisory practice alongside its broader consumer and technology coverage. It competes with TD Cowen on premium healthcare M&A mandates, though its franchise is broader than pure-play healthcare.

Broad incumbents

  • Goldman Sachs Healthcare Investment Banking: Goldman Sachs' Global Healthcare Group is the bulge-bracket leader in healthcare M&A and equity capital markets. It competes with TD Cowen on large-cap healthcare deals and sets the league-table standard the firm benchmarks against.
  • JP Morgan Healthcare Investment Banking: JP Morgan runs one of the largest healthcare investment banking franchises globally, covering biopharma, medical devices, and healthcare services. It competes with TD Cowen across the healthcare M&A spectrum and represents the dominant bulge-bracket alternative.
  • Lazard Healthcare: Lazard operates a dedicated healthcare M&A advisory practice as part of its broader financial advisory franchise. It is directly comparable to TD Cowen's healthcare advisory work but operates at a higher average deal size and broader sector scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Cowen Healthcare Investments social profiles

Digital presence

Cowen Healthcare Investments financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cowen Healthcare Investments leadership team

Management profile

Number of profiles

Profiles1 record

Cowen Healthcare Investments funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cowen Healthcare Investments M&A and investment

M&A and investment

M&A

Investments80 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cowen Healthcare Investments

What does Cowen Healthcare Investments do?

Cowen Healthcare Investments, operating as TD Cowen, provides investment banking services to healthcare and life sciences companies. Its core offerings include M&A advisory, capital markets transactions (equity and debt financing), equity research coverage, and strategic advisory tailored to the healthcare sector. The practice leverages TD Securities' institutional platform to deliver full-service investment banking to corporate healthcare clients.

Is Cowen Healthcare Investments a public or private company?

Cowen Healthcare Investments is a private company. It is classified as corporate owned and is currently operating.

When was Cowen Healthcare Investments founded?

Cowen Healthcare Investments was founded in 2016. It employs 1 to 10 people.

Where is Cowen Healthcare Investments based?

Cowen Healthcare Investments is headquartered in New York, United States, in the North America region.

How does Cowen Healthcare Investments make money?

One revenue line is on record: investment Banking Services.

Who are Cowen Healthcare Investments's main competitors?

Direct peers on record are Jefferies Healthcare Group, Guggenheim Securities Healthcare, Piper Sandler Healthcare, Cantor Fitzgerald Healthcare, SVB Securities (First Citizens) and OrbiMed Advisors. Centerview Partners is listed as an emerging player. Broad incumbents are Goldman Sachs Healthcare Investment Banking, JP Morgan Healthcare Investment Banking and Lazard Healthcare.

Does Cowen Healthcare Investments have an API?

No public API is recorded for Cowen Healthcare Investments.

What industry is Cowen Healthcare Investments in?

Cowen Healthcare Investments's product category is Healthcare Investment Banking. Its primary akta.pro industry code is FSAHAAAK, Equity Long/Short — Healthcare Focus. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WsjBlue Owl to Expand Life-Sciences Business with Cowen Investments Acquisition - WSJBlue Owl Capital agreed to acquire about $1 billion in funds managed by Cowen Healthcare Investments, bringing Cowen's life-sciences investment team. The deal expands Blue Owl's presence in the sector, with Cowen Healthcare owned by Toronto-Dominion Bank, which acquired Cowen earlier this year.Pulse 2.0Cowen Healthcare Investments: Over $550 Million Raised For Fourth FundCowen Healthcare Investments closed its fourth fund, CHI IV, with $555.6 million in committed capital from institutional investors, wealth managers, family offices, and high-net-worth individuals. The fund will invest primarily in mid- to late-stage life sciences opportunities, including biopharma, diagnostics, and digital health.GlobeNewswireCowen Healthcare Investments Successfully Raises Over $550 Million for Fourth FundCowen Healthcare Investments closed its fourth fund, CHI IV, with $555.6 million in committed capital from institutional investors, wealth managers, family offices, and high net worth individuals. The fund will invest primarily in mid- to late-stage life sciences opportunities, and the team manages over $1 billion.GlobeNewswireArch Oncology Secures $105 Million Series C FinancingArch Oncology closed a $105 million Series C financing co-led by Eventide Asset Management, Cowen Healthcare Investments, and 3x5 Partners. The proceeds will support clinical progress of its anti-CD47 candidate AO-176 in Phase 1/2 trials for solid tumors and multiple myeloma. The company plans to expand the program to include combination trials with pembrolizumab and standard therapies.GlobeNewswireAmarin to Present at Two Upcoming Investor ConferencesAmarin's CEO John F. Thero will present company updates at two investor conferences in February and March 2021. The SVB Leerink and Cowen conferences are scheduled for February 26 and March 1, with live webcasts available for 30 days.GlobeNewswireATEC to Participate in Upcoming Investor ConferencesAlphatec Holdings announced management will virtually participate in three investor conferences in March 2021. CEO Pat Miles will present at Cowen and Credit Suisse events, while CFO Jeff Black will pre-record a presentation for H.C. Wainwright. Webcasts and materials will be available online for 90 days.GlobeNewswireCowen Healthcare Investments Successfully Raises $493 Million For Third FundCowen Healthcare Investments completed fundraising for its third fund, raising $493 million, $93 million above the original target. The fund, led by Kevin Raidy, Tim Anderson, and Robert Sine, invests in private healthcare companies across biopharma, diagnostics, and digital health. The firm has invested in 38 private healthcare companies since 2012.PR NewswireDynacure to Present at 40th Annual Cowen Healthcare ConferenceDynacure, a clinical-stage drug development company focused on rare and orphan disorders, announced that Chief Financial Officer David Garrett will present at the 40th Annual Cowen Healthcare Conference on March 2, 2020 in Boston. The company is currently developing DYN101, an antisense medicine for Myotubular and Centronuclear Myopathies, in collaboration with Ionis Pharmaceuticals. Dynacure maintains its headquarters in Strasbourg, France and a corporate office in Philadelphia, Pennsylvania.FinSMEsOncorus Raises $79.5M in Series B FinancingOncorus, a Cambridge, Mass.-based oncolytic virus company, closed a $79.5M Series B financing co-led by Cowen Healthcare Investments and Perceptive Advisors. The company will use the funds to advance its lead candidate ONCR-177 into the clinic in early 2020.FinSMEsPliant Therapeutics Raises $62M in Series B FinancingPliant Therapeutics raised $62M in Series B financing led by Cowen Healthcare Investments, with participation from Eventide Asset Management, Schroder Adveq, and others. Kevin Raidy joined the board. The company will use the funds for clinical trials in idiopathic pulmonary fibrosis and primary sclerosing cholangitis.